Regenerative Hair Therapies Edge Closer to Change, But Transplants Endure
A wave of regenerative treatments—PP405 from Pelage/UCLA, ET-02, VDPHL01, and MuseCells—claims to reactivate dormant follicles, regrow hair, and even address graying, signaling a potential shift in how baldness is treated. However, none are FDA-approved yet and years of testing remain before they reach clinics; meanwhile, demand for traditional hair transplants remains high and doctors view these therapies as likely supplements rather than replacements. The field is early-stage, with ongoing trials and significant funding, so patients should consult physicians and approach claims with caution.
